0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bacteriophage Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-10G5314
Home | Market Reports | Science| Biological Sciences
Global Bacteriophage Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Bacteriophage Market Research Report 2026

Code: QYRE-Auto-10G5314
Report
2026-03-03
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bacteriophage Market Size

The global Bacteriophage market was valued at US$ 61.42 million in 2025 and is anticipated to reach US$ 207 million by 2032, at a CAGR of 19.3% from 2026 to 2032.

Bacteriophage Market

Bacteriophage Market

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Global key players of bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., etc. The top three players hold a share about 34%. Europe is the largest market, has a share about 48%. In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%. In terms of application, Animal Health has a share about 51 percent.
This report delivers a comprehensive overview of the global Bacteriophage market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Bacteriophage. The Bacteriophage market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Bacteriophage market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Bacteriophage manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Bacteriophage Market Report

Report Metric Details
Report Name Bacteriophage Market
Accounted market size in 2025 US$ 61.42 million
Forecasted market size in 2032 US$ 207 million
CAGR 19.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • DsDNA Bacteriophage
  • SsDNA Bacteriophage
  • SsRNA Bacteriophage
  • Others
Segment by Application
  • Animal Health
  • Aquaculture
  • Agriculture
  • Food Industry
  • Human Health
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), ACD Pharma, Proteon Pharmaceuticals, Micreos, Locus Biosciences, Inc, NexaBiome Limited, PhagePro, BiomX, INtODEWORLD, Inc., TechnoPhage
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Bacteriophage companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Bacteriophage Market growing?

Ans: The Bacteriophage Market witnessing a CAGR of 19.3% during the forecast period 2026-2032.

What is the Bacteriophage Market size in 2032?

Ans: The Bacteriophage Market size in 2032 will be US$ 207 million.

What is the market share of major companies in Bacteriophage Market?

Ans: The top three players hold a share about 34%.

What is the Bacteriophage Market share by region?

Ans: Europe is the largest market, has a share about 48%.

What is the Bacteriophage Market share by type?

Ans: In terms of product type, DsDNA Bacteriophage is the largest segment, occupied for a share of 91%.

Who are the main players in the Bacteriophage Market report?

Ans: The main players in the Bacteriophage Market are NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, Pharmex Group, LLC, APS Biocontrol Ltd. (APS), ACD Pharma, Proteon Pharmaceuticals, Micreos, Locus Biosciences, Inc, NexaBiome Limited, PhagePro, BiomX, INtODEWORLD, Inc., TechnoPhage

What are the Application segmentation covered in the Bacteriophage Market report?

Ans: The Applications covered in the Bacteriophage Market report are Animal Health, Aquaculture, Agriculture, Food Industry, Human Health, Others

What are the Type segmentation covered in the Bacteriophage Market report?

Ans: The Types covered in the Bacteriophage Market report are DsDNA Bacteriophage, SsDNA Bacteriophage, SsRNA Bacteriophage, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bacteriophage Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Bacteriophage Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Animal Health
1.3.3 Aquaculture
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Human Health
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bacteriophage Market Perspective (2021–2032)
2.2 Global Bacteriophage Growth Trends by Region
2.2.1 Global Bacteriophage Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Bacteriophage Historic Market Size by Region (2021–2026)
2.2.3 Bacteriophage Forecasted Market Size by Region (2027–2032)
2.3 Bacteriophage Market Dynamics
2.3.1 Bacteriophage Industry Trends
2.3.2 Bacteriophage Market Drivers
2.3.3 Bacteriophage Market Challenges
2.3.4 Bacteriophage Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bacteriophage Players by Revenue
3.1.1 Global Top Bacteriophage Players by Revenue (2021–2026)
3.1.2 Global Bacteriophage Revenue Market Share by Players (2021–2026)
3.2 Global Top Bacteriophage Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Bacteriophage Revenue
3.4 Global Bacteriophage Market Concentration Ratio
3.4.1 Global Bacteriophage Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bacteriophage Revenue in 2025
3.5 Global Key Players of Bacteriophage Head Offices and Areas Served
3.6 Global Key Players of Bacteriophage, Products and Applications
3.7 Global Key Players of Bacteriophage, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Bacteriophage Breakdown Data by Type
4.1 Global Bacteriophage Historic Market Size by Type (2021–2026)
4.2 Global Bacteriophage Forecasted Market Size by Type (2027–2032)
5 Bacteriophage Breakdown Data by Application
5.1 Global Bacteriophage Historic Market Size by Application (2021–2026)
5.2 Global Bacteriophage Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Bacteriophage Market Size (2021–2032)
6.2 North America Bacteriophage Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Bacteriophage Market Size by Country (2021–2026)
6.4 North America Bacteriophage Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bacteriophage Market Size (2021–2032)
7.2 Europe Bacteriophage Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Bacteriophage Market Size by Country (2021–2026)
7.4 Europe Bacteriophage Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Bacteriophage Market Size (2021–2032)
8.2 Asia-Pacific Bacteriophage Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Bacteriophage Market Size by Region (2021–2026)
8.4 Asia-Pacific Bacteriophage Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Bacteriophage Market Size (2021–2032)
9.2 Latin America Bacteriophage Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Bacteriophage Market Size by Country (2021–2026)
9.4 Latin America Bacteriophage Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bacteriophage Market Size (2021–2032)
10.2 Middle East & Africa Bacteriophage Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Bacteriophage Market Size by Country (2021–2026)
10.4 Middle East & Africa Bacteriophage Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Details
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Bacteriophage Introduction
11.1.4 NPO Microgen Revenue in Bacteriophage Business (2021–2026)
11.1.5 NPO Microgen Recent Development
11.2 Qingdao Phagepharm Bio-tech
11.2.1 Qingdao Phagepharm Bio-tech Company Details
11.2.2 Qingdao Phagepharm Bio-tech Business Overview
11.2.3 Qingdao Phagepharm Bio-tech Bacteriophage Introduction
11.2.4 Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2021–2026)
11.2.5 Qingdao Phagepharm Bio-tech Recent Development
11.3 Armata Pharmaceuticals, Inc.
11.3.1 Armata Pharmaceuticals, Inc. Company Details
11.3.2 Armata Pharmaceuticals, Inc. Business Overview
11.3.3 Armata Pharmaceuticals, Inc. Bacteriophage Introduction
11.3.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2021–2026)
11.3.5 Armata Pharmaceuticals, Inc. Recent Development
11.4 Phaxiam Therapeutics
11.4.1 Phaxiam Therapeutics Company Details
11.4.2 Phaxiam Therapeutics Business Overview
11.4.3 Phaxiam Therapeutics Bacteriophage Introduction
11.4.4 Phaxiam Therapeutics Revenue in Bacteriophage Business (2021–2026)
11.4.5 Phaxiam Therapeutics Recent Development
11.5 Eliava BioPreparations
11.5.1 Eliava BioPreparations Company Details
11.5.2 Eliava BioPreparations Business Overview
11.5.3 Eliava BioPreparations Bacteriophage Introduction
11.5.4 Eliava BioPreparations Revenue in Bacteriophage Business (2021–2026)
11.5.5 Eliava BioPreparations Recent Development
11.6 Intralytix
11.6.1 Intralytix Company Details
11.6.2 Intralytix Business Overview
11.6.3 Intralytix Bacteriophage Introduction
11.6.4 Intralytix Revenue in Bacteriophage Business (2021–2026)
11.6.5 Intralytix Recent Development
11.7 MicroMir
11.7.1 MicroMir Company Details
11.7.2 MicroMir Business Overview
11.7.3 MicroMir Bacteriophage Introduction
11.7.4 MicroMir Revenue in Bacteriophage Business (2021–2026)
11.7.5 MicroMir Recent Development
11.8 Phagelux
11.8.1 Phagelux Company Details
11.8.2 Phagelux Business Overview
11.8.3 Phagelux Bacteriophage Introduction
11.8.4 Phagelux Revenue in Bacteriophage Business (2021–2026)
11.8.5 Phagelux Recent Development
11.9 Pharmex Group, LLC
11.9.1 Pharmex Group, LLC Company Details
11.9.2 Pharmex Group, LLC Business Overview
11.9.3 Pharmex Group, LLC Bacteriophage Introduction
11.9.4 Pharmex Group, LLC Revenue in Bacteriophage Business (2021–2026)
11.9.5 Pharmex Group, LLC Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Details
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Bacteriophage Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2021–2026)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 ACD Pharma
11.11.1 ACD Pharma Company Details
11.11.2 ACD Pharma Business Overview
11.11.3 ACD Pharma Bacteriophage Introduction
11.11.4 ACD Pharma Revenue in Bacteriophage Business (2021–2026)
11.11.5 ACD Pharma Recent Development
11.12 Proteon Pharmaceuticals
11.12.1 Proteon Pharmaceuticals Company Details
11.12.2 Proteon Pharmaceuticals Business Overview
11.12.3 Proteon Pharmaceuticals Bacteriophage Introduction
11.12.4 Proteon Pharmaceuticals Revenue in Bacteriophage Business (2021–2026)
11.12.5 Proteon Pharmaceuticals Recent Development
11.13 Micreos
11.13.1 Micreos Company Details
11.13.2 Micreos Business Overview
11.13.3 Micreos Bacteriophage Introduction
11.13.4 Micreos Revenue in Bacteriophage Business (2021–2026)
11.13.5 Micreos Recent Development
11.14 Locus Biosciences, Inc
11.14.1 Locus Biosciences, Inc Company Details
11.14.2 Locus Biosciences, Inc Business Overview
11.14.3 Locus Biosciences, Inc Bacteriophage Introduction
11.14.4 Locus Biosciences, Inc Revenue in Bacteriophage Business (2021–2026)
11.14.5 Locus Biosciences, Inc Recent Development
11.15 NexaBiome Limited
11.15.1 NexaBiome Limited Company Details
11.15.2 NexaBiome Limited Business Overview
11.15.3 NexaBiome Limited Bacteriophage Introduction
11.15.4 NexaBiome Limited Revenue in Bacteriophage Business (2021–2026)
11.15.5 NexaBiome Limited Recent Development
11.16 PhagePro
11.16.1 PhagePro Company Details
11.16.2 PhagePro Business Overview
11.16.3 PhagePro Bacteriophage Introduction
11.16.4 PhagePro Revenue in Bacteriophage Business (2021–2026)
11.16.5 PhagePro Recent Development
11.17 BiomX
11.17.1 BiomX Company Details
11.17.2 BiomX Business Overview
11.17.3 BiomX Bacteriophage Introduction
11.17.4 BiomX Revenue in Bacteriophage Business (2021–2026)
11.17.5 BiomX Recent Development
11.18 INtODEWORLD, Inc.
11.18.1 INtODEWORLD, Inc. Company Details
11.18.2 INtODEWORLD, Inc. Business Overview
11.18.3 INtODEWORLD, Inc. Bacteriophage Introduction
11.18.4 INtODEWORLD, Inc. Revenue in Bacteriophage Business (2021–2026)
11.18.5 INtODEWORLD, Inc. Recent Development
11.19 TechnoPhage
11.19.1 TechnoPhage Company Details
11.19.2 TechnoPhage Business Overview
11.19.3 TechnoPhage Bacteriophage Introduction
11.19.4 TechnoPhage Revenue in Bacteriophage Business (2021–2026)
11.19.5 TechnoPhage Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Bacteriophage Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of DsDNA Bacteriophage
 Table 3. Key Players of SsDNA Bacteriophage
 Table 4. Key Players of SsRNA Bacteriophage
 Table 5. Key Players of Others
 Table 6. Global Bacteriophage Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Bacteriophage Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Bacteriophage Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Bacteriophage Market Share by Region (2021–2026)
 Table 10. Global Bacteriophage Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Bacteriophage Market Share by Region (2027–2032)
 Table 12. Bacteriophage Market Trends
 Table 13. Bacteriophage Market Drivers
 Table 14. Bacteriophage Market Challenges
 Table 15. Bacteriophage Market Restraints
 Table 16. Global Bacteriophage Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Bacteriophage Market Share by Players (2021–2026)
 Table 18. Global Top Bacteriophage Players by Tier (Tier 1, Tier 2, and Tier 3), based on Bacteriophage Revenue, 2025
 Table 19. Ranking of Global Top Bacteriophage Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Bacteriophage Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Bacteriophage, Headquarters and Area Served
 Table 22. Global Key Players of Bacteriophage, Products and Applications
 Table 23. Global Key Players of Bacteriophage, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Bacteriophage Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Bacteriophage Revenue Market Share by Type (2021–2026)
 Table 27. Global Bacteriophage Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Bacteriophage Revenue Market Share by Type (2027–2032)
 Table 29. Global Bacteriophage Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Bacteriophage Revenue Market Share by Application (2021–2026)
 Table 31. Global Bacteriophage Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Bacteriophage Revenue Market Share by Application (2027–2032)
 Table 33. North America Bacteriophage Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Bacteriophage Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Bacteriophage Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Bacteriophage Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Bacteriophage Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Bacteriophage Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Bacteriophage Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Bacteriophage Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Bacteriophage Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Bacteriophage Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Bacteriophage Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Bacteriophage Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Bacteriophage Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Bacteriophage Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Bacteriophage Market Size by Country (US$ Million), 2027–2032
 Table 48. NPO Microgen Company Details
 Table 49. NPO Microgen Business Overview
 Table 50. NPO Microgen Bacteriophage Product
 Table 51. NPO Microgen Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 52. NPO Microgen Recent Development
 Table 53. Qingdao Phagepharm Bio-tech Company Details
 Table 54. Qingdao Phagepharm Bio-tech Business Overview
 Table 55. Qingdao Phagepharm Bio-tech Bacteriophage Product
 Table 56. Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 57. Qingdao Phagepharm Bio-tech Recent Development
 Table 58. Armata Pharmaceuticals, Inc. Company Details
 Table 59. Armata Pharmaceuticals, Inc. Business Overview
 Table 60. Armata Pharmaceuticals, Inc. Bacteriophage Product
 Table 61. Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 62. Armata Pharmaceuticals, Inc. Recent Development
 Table 63. Phaxiam Therapeutics Company Details
 Table 64. Phaxiam Therapeutics Business Overview
 Table 65. Phaxiam Therapeutics Bacteriophage Product
 Table 66. Phaxiam Therapeutics Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 67. Phaxiam Therapeutics Recent Development
 Table 68. Eliava BioPreparations Company Details
 Table 69. Eliava BioPreparations Business Overview
 Table 70. Eliava BioPreparations Bacteriophage Product
 Table 71. Eliava BioPreparations Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 72. Eliava BioPreparations Recent Development
 Table 73. Intralytix Company Details
 Table 74. Intralytix Business Overview
 Table 75. Intralytix Bacteriophage Product
 Table 76. Intralytix Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 77. Intralytix Recent Development
 Table 78. MicroMir Company Details
 Table 79. MicroMir Business Overview
 Table 80. MicroMir Bacteriophage Product
 Table 81. MicroMir Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 82. MicroMir Recent Development
 Table 83. Phagelux Company Details
 Table 84. Phagelux Business Overview
 Table 85. Phagelux Bacteriophage Product
 Table 86. Phagelux Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 87. Phagelux Recent Development
 Table 88. Pharmex Group, LLC Company Details
 Table 89. Pharmex Group, LLC Business Overview
 Table 90. Pharmex Group, LLC Bacteriophage Product
 Table 91. Pharmex Group, LLC Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 92. Pharmex Group, LLC Recent Development
 Table 93. APS Biocontrol Ltd. (APS) Company Details
 Table 94. APS Biocontrol Ltd. (APS) Business Overview
 Table 95. APS Biocontrol Ltd. (APS) Bacteriophage Product
 Table 96. APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 97. APS Biocontrol Ltd. (APS) Recent Development
 Table 98. ACD Pharma Company Details
 Table 99. ACD Pharma Business Overview
 Table 100. ACD Pharma Bacteriophage Product
 Table 101. ACD Pharma Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 102. ACD Pharma Recent Development
 Table 103. Proteon Pharmaceuticals Company Details
 Table 104. Proteon Pharmaceuticals Business Overview
 Table 105. Proteon Pharmaceuticals Bacteriophage Product
 Table 106. Proteon Pharmaceuticals Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 107. Proteon Pharmaceuticals Recent Development
 Table 108. Micreos Company Details
 Table 109. Micreos Business Overview
 Table 110. Micreos Bacteriophage Product
 Table 111. Micreos Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 112. Micreos Recent Development
 Table 113. Locus Biosciences, Inc Company Details
 Table 114. Locus Biosciences, Inc Business Overview
 Table 115. Locus Biosciences, Inc Bacteriophage Product
 Table 116. Locus Biosciences, Inc Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 117. Locus Biosciences, Inc Recent Development
 Table 118. NexaBiome Limited Company Details
 Table 119. NexaBiome Limited Business Overview
 Table 120. NexaBiome Limited Bacteriophage Product
 Table 121. NexaBiome Limited Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 122. NexaBiome Limited Recent Development
 Table 123. PhagePro Company Details
 Table 124. PhagePro Business Overview
 Table 125. PhagePro Bacteriophage Product
 Table 126. PhagePro Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 127. PhagePro Recent Development
 Table 128. BiomX Company Details
 Table 129. BiomX Business Overview
 Table 130. BiomX Bacteriophage Product
 Table 131. BiomX Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 132. BiomX Recent Development
 Table 133. INtODEWORLD, Inc. Company Details
 Table 134. INtODEWORLD, Inc. Business Overview
 Table 135. INtODEWORLD, Inc. Bacteriophage Product
 Table 136. INtODEWORLD, Inc. Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 137. INtODEWORLD, Inc. Recent Development
 Table 138. TechnoPhage Company Details
 Table 139. TechnoPhage Business Overview
 Table 140. TechnoPhage Bacteriophage Product
 Table 141. TechnoPhage Revenue in Bacteriophage Business (US$ Million), 2021–2026
 Table 142. TechnoPhage Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Bacteriophage Picture
 Figure 2. Global Bacteriophage Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Bacteriophage Market Share by Type: 2025 vs 2032
 Figure 4. DsDNA Bacteriophage Features
 Figure 5. SsDNA Bacteriophage Features
 Figure 6. SsRNA Bacteriophage Features
 Figure 7. Others Features
 Figure 8. Global Bacteriophage Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Bacteriophage Market Share by Application: 2025 vs 2032
 Figure 10. Animal Health Case Studies
 Figure 11. Aquaculture Case Studies
 Figure 12. Agriculture Case Studies
 Figure 13. Food Industry Case Studies
 Figure 14. Human Health Case Studies
 Figure 15. Others Case Studies
 Figure 16. Bacteriophage Report Years Considered
 Figure 17. Global Bacteriophage Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 18. Global Bacteriophage Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 19. Global Bacteriophage Market Share by Region: 2025 vs 2032
 Figure 20. Global Bacteriophage Market Share by Players in 2025
 Figure 21. Global Bacteriophage Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 22. The Top 10 and 5 Players Market Share by Bacteriophage Revenue in 2025
 Figure 23. North America Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. North America Bacteriophage Market Share by Country (2021–2032)
 Figure 25. United States Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Canada Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Europe Bacteriophage Market Share by Country (2021–2032)
 Figure 29. Germany Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. France Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. U.K. Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Italy Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Russia Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Ireland Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Asia-Pacific Bacteriophage Market Share by Region (2021–2032)
 Figure 37. China Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Japan Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. South Korea Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Southeast Asia Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. India Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Australia & New Zealand Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Latin America Bacteriophage Market Share by Country (2021–2032)
 Figure 45. Mexico Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Brazil Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Middle East & Africa Bacteriophage Market Share by Country (2021–2032)
 Figure 49. Israel Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. UAE Bacteriophage Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. NPO Microgen Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 53. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 54. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 55. Phaxiam Therapeutics Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 56. Eliava BioPreparations Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 57. Intralytix Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 58. MicroMir Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 59. Phagelux Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 60. Pharmex Group, LLC Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 61. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 62. ACD Pharma Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 63. Proteon Pharmaceuticals Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 64. Micreos Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 65. Locus Biosciences, Inc Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 66. NexaBiome Limited Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 67. PhagePro Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 68. BiomX Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 69. INtODEWORLD, Inc. Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 70. TechnoPhage Revenue Growth Rate in Bacteriophage Business (2021–2026)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI